1. Home
  2. STXS vs NB Comparison

STXS vs NB Comparison

Compare STXS & NB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • NB
  • Stock Information
  • Founded
  • STXS 1990
  • NB 1987
  • Country
  • STXS United States
  • NB United States
  • Employees
  • STXS N/A
  • NB N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NB Metal Mining
  • Sector
  • STXS Health Care
  • NB Basic Materials
  • Exchange
  • STXS Nasdaq
  • NB Nasdaq
  • Market Cap
  • STXS 151.3M
  • NB 132.6M
  • IPO Year
  • STXS 2004
  • NB N/A
  • Fundamental
  • Price
  • STXS $2.11
  • NB $2.48
  • Analyst Decision
  • STXS
  • NB Strong Buy
  • Analyst Count
  • STXS 0
  • NB 2
  • Target Price
  • STXS N/A
  • NB $4.13
  • AVG Volume (30 Days)
  • STXS 224.8K
  • NB 478.6K
  • Earning Date
  • STXS 05-12-2025
  • NB 05-08-2025
  • Dividend Yield
  • STXS N/A
  • NB N/A
  • EPS Growth
  • STXS N/A
  • NB N/A
  • EPS
  • STXS N/A
  • NB N/A
  • Revenue
  • STXS $27,510,000.00
  • NB N/A
  • Revenue This Year
  • STXS $25.90
  • NB N/A
  • Revenue Next Year
  • STXS $60.57
  • NB N/A
  • P/E Ratio
  • STXS N/A
  • NB N/A
  • Revenue Growth
  • STXS 1.50
  • NB N/A
  • 52 Week Low
  • STXS $1.54
  • NB $1.27
  • 52 Week High
  • STXS $2.72
  • NB $4.15
  • Technical
  • Relative Strength Index (RSI)
  • STXS 57.13
  • NB 53.50
  • Support Level
  • STXS $2.07
  • NB $2.25
  • Resistance Level
  • STXS $2.17
  • NB $2.64
  • Average True Range (ATR)
  • STXS 0.10
  • NB 0.15
  • MACD
  • STXS -0.00
  • NB -0.00
  • Stochastic Oscillator
  • STXS 80.03
  • NB 63.74

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About NB NioCorp Developments Ltd.

NioCorp Developments Ltd is engaged in exploration and development of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property.

Share on Social Networks: